Authored Items
Considerations in Non-Hodgkin's Lymphoma: Clinical Trial Updates
André Goy, MD, MS, Amanda Copeland, MSN, RN, CNS, Anas Younes, MD, Sandra E. Kurtin, RN, MS, AOCN, ANP-C, Nelly G. Adel, PharmD, BCOP, BCPS
Supplements
Considerations in Non-Hodgkin's Lymphoma: T-Cell Lymphomas
Andrei Shustov, MD, Nora M. Mueller, PharmD, André Goy, MD, MS
Supplements
Considerations in Non-Hodgkin's Lymphoma: Diffuse Large B-Cell Lymphoma
André Goy, MD, MS, Betty M. Chan, PharmD, BCOP, Christine Liebertz, RN, CS, MSN, AOCN
Supplements
Considerations in Non-Hodgkin's Lymphoma: Waldenstrom's Macroglobulinemia
André Goy, MD, MS, Amy Goodrich, RN, MSN, CRNP, Zaven R. Norigian, PharmD, BCOP
Supplements
Considerations in Non-Hodgkin's Lymphoma: Follicular Lymphoma
André Goy, MD, MS, Andrew M. Evens, DO, MSc, Sonja Crandon, RN, BSN, Cindy L. O'Bryant, PharmD, BCOP
Supplements
Considerations in Non-Hodgkin's Lymphoma: Mantle Cell Lymphoma
André Goy, MD, MS, Steven H. Bernstein, MD
Supplements
Last modified: November 17, 2010